|
⚲
|
| Keyboard |
| Ligand Pharmaceuticals Inc
✚
|
|
|---|---|
| CIK # | 0000886163 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0000886163] | |
| 10-Q | [0000886163] | |
| 3 | [0000886163] | |
| 4 | [0000886163] | |
| 5 | [0000886163] | |
| 8-K | [0000886163] | |
| D | [0000886163] | |
| SC 13D | [0000886163] | |
| SC 13G | [0000886163] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Davis Todd C | |
| Ligand Pharmaceuticals Inc | |
| Reardon Andrew | |
| Espinoza Octavio | |
| Sabba Stephen L | |
| Haas Jason | |
| Lamattina John L | |
| Aryeh Jason | |
| Zimmermann Martine | |
| Kozarich John W | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-23 | Sell | 1,000 | $207.87 | 207,870 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-11 | Option exercise | 2,405 | $92.65 | 222,823 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-11 | Sell | 3,057 | $225.00 | 687,825 |
|
Ligand Pharmaceuticals Inc LGND
Employee Stock Option (right to buy) · derivative
|
2026-03-11 | Option exercise | 2,405 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-06 | Sell | 2,161 | $200.76 | 433,842 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-06 | Option exercise | 2,161 | $114.15 | 246,678 |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-06 | Option exercise | 2,161 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Employee Stock Option (right to buy) · derivative
|
2026-03-04 | Option exercise | 5,000 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Sell | 200 | $204.17 | 40,834 |
|
Ligand Pharmaceuticals Inc LGND
Employee Stock Option (right to buy) · derivative
|
2026-03-04 | Option exercise | 1,607 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Sell | 340 | $206.37 | 70,166 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Sell | 100 | $199.01 | 19,901 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Sell | 950 | $201.73 | 191,644 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Option exercise | 1,607 | $58.49 | 93,993 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Sell | 1,457 | $205.79 | 299,836 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Sell | 100 | $197.70 | 19,770 |
|
Ligand Pharmaceuticals Inc LGND
Employee Stock Option (right to buy) · derivative
|
2026-03-04 | Option exercise | 466 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Sell | 53 | $200.08 | 10,604 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Sell | 2,457 | $207.91 | 510,835 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-04 | Sell | 460 | $205.18 | 94,383 |
| showing 20 of 200 most recent transactions | |||||